vimarsana.com

Page 5 - புனே சீரம் நிறுவனம் ஆஃப் இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vaccinated people better protected against Covid but can still transmit disease: experts

URL copied Vaccinated people better protected against Covid but can still transmit disease: experts COVID-19 vaccines protect against serious illness but transmissibility can still continue and inoculated people can pass on the infection to others, say scientists, warning against complacency in those who stop maintaining protocol after they get their jabs. Transmissibility from vaccinated persons can be a risk factor until global coverage is achieved, top experts said as India’s Covid numbers escalated sharply, reaching 1,35,27,717 (1.35 crore/13,5 million) with 1,68,912 new cases on Monday to make it the country with the second highest number of cases after the US. “Vaccination is simply one of the many different strategies we have to deal with in the pandemic. However, it is not a magical one-stop solution,” immunologist Satyajit Rath, from the New Delhi’s National Institute of Immunology, told PTI.

COVID-19 recovered people showing faster antibody response to Serum Institute vaccine Covishield, says study

COVID-19 recovered people showing faster antibody response to Serum Institute vaccine Covishield, says study
medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.

A lot of catching up to do : How is India s vaccination drive going?

‘A lot of catching up to do’: How is India’s vaccination drive going? Will the government meet its ambitious target of vaccinating 30 crore people by August? Experts weigh in. Kartik Kakar Earlier this week, India commenced the next step in its mammoth undertaking of vaccinating its 136.6 crore citizens against Covid. With healthcare workers and essential workers receiving their doses first, the vaccines are now being made available for those over 60 years of age and those above 45 with comorbidities. India approved two vaccines for emergency use on January 3 – Oxford-AstraZeneca’s Covishield, produced by Pune’s Serum Institute of India, and Bharat Biotech’s Covaxin. The latter has been at the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.